UiPath Stock: RPA Leader In Buy Zone, 2 Caveats (NYSE:PATH)

We were lukewarm to UiPath due to its premium valuation but the stock got battered recently. Why did PATH drop? Why do we think PATH is in the BUY zone? Find out.

Related Keywords

, Noam Galai Getty , Manufacturing Institute , Deloitte , Techcrunch Disrupt Berlin , Getty Images , Public Comps , Uipath Stock ,